Search Results

There are 28692 results for: content related to: Minimal Residual Disease Detection in Acute Myeloid Leukemia by RQ-PCR and Multiparameter Flow Cytometry

  1. You have free access to this content
    Monitoring of minimal residual disease in acute myeloid leukemia

    Cancer

    Volume 112, Issue 1, 1 January 2008, Pages: 4–16, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach and Susanne Schnittger

    Version of Record online : 13 NOV 2007, DOI: 10.1002/cncr.23128

  2. You have free access to this content
    Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findings

    Cytometry Part B: Clinical Cytometry

    Volume 62B, Issue 1, November 2004, Pages: 25–38, Daniela Voskova, Claudia Schoch, Susanne Schnittger, Wolfgang Hiddemann, Torsten Haferlach and Wolfgang Kern

    Version of Record online : 4 OCT 2004, DOI: 10.1002/cyto.b.20025

  3. Acute Leukaemia: Integration of Morphological, Immunophenotypic and Genetic Information and the WHO Classification

    Leukaemia Diagnosis, Fourth Edition

    Barbara J. Bain, Pages: 114–218, 2010

    Published Online : 30 JUN 2010, DOI: 10.1002/9781444318470.ch3

  4. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia

    American Journal of Hematology

    Volume 90, Issue 6, June 2015, Pages: 504–510, Juan Ouyang, Maitrayee Goswami, Guilin Tang, Jie Peng, Farhad Ravandi, Naval Daver, Mark Routbort, Sergej Konoplev, Pei Lin, L. Jeffrey Medeiros, Jeffrey L. Jorgensen and Sa A. Wang

    Version of Record online : 2 APR 2015, DOI: 10.1002/ajh.23988

  5. You have free access to this content
    The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

    Cytometry Part B: Clinical Cytometry

    Volume 76B, Issue 2, March 2009, Pages: 91–101, Adhra Al-Mawali, David Gillis and Ian Lewis

    Version of Record online : 25 AUG 2008, DOI: 10.1002/cyto.b.20444

  6. You have free access to this content
    Evaluation of complete disease remission in acute myeloid leukemia

    Cancer

    Volume 106, Issue 4, 15 February 2006, Pages: 839–847, Ulrike Bacher, Wolfgang Kern, Claudia Schoch, Susanne Schnittger, Wolfgang Hiddemann and Torsten Haferlach

    Version of Record online : 17 JAN 2006, DOI: 10.1002/cncr.21665

  7. You have free access to this content
    Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring

    Cytometry Part B: Clinical Cytometry

    Volume 63B, Issue 1, January 2005, Pages: 1–9, Claudia Langebrake, Iris Brinkmann, Andrea Teigler-Schlegel, Ursula Creutzig, Frank Griesinger, Ulrike Puhlmann and Dirk Reinhardt

    Version of Record online : 10 DEC 2004, DOI: 10.1002/cyto.b.20037

  8. You have free access to this content
    Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations

    British Journal of Haematology

    Volume 152, Issue 6, March 2011, Pages: 713–720, Ulrike Bacher, Torsten Haferlach, Tamara Alpermann, Melanie Zenger, Andreas Hochhaus, Dietrich W. Beelen, Michael Uppenkamp, Mathias Rummel, Wolfgang Kern, Susanne Schnittger and Claudia Haferlach

    Version of Record online : 31 JAN 2011, DOI: 10.1111/j.1365-2141.2010.08472.x

  9. Leukemia blast cell identification

    Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery

    Volume 5, Issue 2, March/April 2015, Pages: 74–85, Frida Rizzati, Barbara Buldini and Giuseppe Basso

    Version of Record online : 23 FEB 2015, DOI: 10.1002/widm.1146

  10. You have free access to this content
    Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy

    American Journal of Hematology

    Volume 89, Issue 12, December 2014, Pages: 1121–1131, Melhem Solh, Sophia Yohe, Daniel Weisdorf and Celalettin Ustun

    Version of Record online : 27 AUG 2014, DOI: 10.1002/ajh.23821

  11. The detection and significance of minimal residual disease in acute and chronic leukemia

    Tissue Antigens

    Volume 68, Issue 5, November 2006, Pages: 371–385, N.-G. Chung, V. Buxhofer-Ausch and J. P. Radich

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1399-0039.2006.00714.x

  12. Non-Cytogenetic Markers and their Impact on Prognosis

    Leukemias: Principles and Practice of Therapy

    Eric Schafer, Donald Small, Pages: 56–76, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch5

  13. Presentation and Diagnosis: Novel Molecular Markers and their Role in the Prognosis and Therapy of Acute Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Wolfgang Kern, Torsten Haferlach, Susanne Schnittger, Claudia Haferlach, Ulrike Bacher, Pages: 115–124, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch9

  14. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next generation sequencing

    European Journal of Haematology

    Accepted manuscript online: 20 MAY 2016, Erik BR Malmberg, Sara Ståhlman, Anna Rehammar, Tore Samuelsson, Sofie J Alm, Erik Kristiansson, Jonas Abrahamsson, Hege Garelius, Louise Pettersson, Mats Ehinger, Lars Palmqvist and Linda Fogelstrand

    DOI: 10.1111/ejh.12780

  15. Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT–PCR useful clinically?

    European Journal of Haematology

    Volume 71, Issue 3, September 2003, Pages: 143–154, Guido Marcucci, Michael A. Caligiuri and Clara D. Bloomfield

    Version of Record online : 20 AUG 2003, DOI: 10.1034/j.1600-0609.2003.00131.x

  16. Development of a biochip-based assay integrated in a global strategy for identification of fusion transcripts in acute myeloid leukemia: a work flow for acute myeloid leukemia diagnosis

    International Journal of Laboratory Hematology

    Volume 32, Issue 4, August 2010, Pages: 398–409, S. GIUSIANO, C. FORMISANO-TRÉZINY, A. BENZIANE, N. MAROC, C. PICARD, F. HERMITTE, C. TARANGER-CHARPIN and J. GABERT

    Version of Record online : 23 NOV 2009, DOI: 10.1111/j.1751-553X.2009.01201.x

  17. You have free access to this content
    Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance

    British Journal of Haematology

    Volume 106, Issue 3, September 1999, Pages: 578–590, John A. Liu Yin and Khalid Tobal

    Version of Record online : 23 FEB 2002, DOI: 10.1046/j.1365-2141.1999.01522.x

  18. The Detection and Significance of Minimal Residual Disease

    Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

    Jerald P. Radich, Marilyn L. Slovak, Pages: 376–389, 2009

    Published Online : 5 MAR 2009, DOI: 10.1002/9781444303537.ch26

  19. The Detection and Significance of Minimal Residual Disease

    Thomas' Hematopoietic Cell Transplantation, Third Edition

    Jerald P. Radich, Marilyn L. Slovak, Pages: 272–285, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987070.ch22

  20. You have free access to this content
    Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms

    British Journal of Haematology

    Volume 153, Issue 4, May 2011, Pages: 421–436, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht and Gerrit Jan Schuurhuis

    Version of Record online : 9 MAR 2011, DOI: 10.1111/j.1365-2141.2011.08595.x